Journal article
5.29 Potential of AFX-2, a Unique, Polysaccharide-Based Toll-like Receptor Agonist, in Patients With Chronic Lymphocytic Leukemia
Authors
Sagar SM; High KP; Shaw EG; Lutsiak C; Sutherland S; Shan J
Journal
Clinical Lymphoma Myeloma & Leukemia, Vol. 11, , pp. s262–s263
Publisher
Elsevier
Publication Date
10 2011
DOI
10.1016/j.clml.2011.09.183
ISSN
2152-2650